Regulation
Germany's New Cannabis Medicine Exilby Launches Amid Reimbursement Shake-Up
Vertanical's Exilby oral extract debuts weeks after dried cannabis flowers lost national health reimbursement, giving the new pharmaceutical a regulatory edge but raising patient access concerns.
Read the evidence-backed report →